NeuraMedica
Oregon City, US · Founded 2014 · Delaware corporation
BiotechHealthtech
Founders & leadership
NR
Neil RoundyExecutive Officer, Director, Promoter
RD
Rachel DreilingerExecutive Officer, Director, Promoter
CR
Coni RosatiDirector, Promoter
MT
Michael TippieDirector
Reported raises · per SEC filings
Form D private placements▶$709.6KraisedNov 2024 · 13 investors · BiotechnologyRule 506(b)
▶$709.6KraisedNov 2024 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael TippieDirector
- Neil RoundyExecutive Officer, Director, Promoter
- Rachel DreilingerExecutive Officer, Director, Promoter
- Offering amount
- $1M
- Amount sold
- $709.6K
- Proceeds to insiders
- $67.8K
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.1MraisedFeb 2021 · 5 investors · BiotechnologyRule 506(b)
▶$1.1MraisedFeb 2021 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Rachel DreilingerExecutive Officer, Director, Promoter
- Neil RoundyDirector, Promoter
- John AllemanDirector
- Offering amount
- $1.1M
- Amount sold
- $1.1M
- Proceeds to insiders
- $95.8K
- First sale
- Jan 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$40KraisedJun 2018 · 2 investors · Other Health CareRule 506(b)
▶$40KraisedJun 2018 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michael TippieExecutive Officer, Promoter
- Rachel DreilingerExecutive Officer, Director, Promoter
- Coni RosatiDirector, Promoter
- Neil RoundyExecutive Officer, Director
- Offering amount
- $150K
- Amount sold
- $40K
- First sale
- Jun 2018
- Incorporated
- Corporation, Oregon, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2018 | $1.5M |
| National Science Foundation | Phase I | 2017 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.